SC 13G/A: Profound Medical Corp.

Ticker: PROF · Form: SC 13G/A · Filed: Mar 13, 2024 · CIK: 1628808

Profound Medical Corp. SC 13G/A Filing Summary
FieldDetail
CompanyProfound Medical Corp. (PROF)
Form TypeSC 13G/A
Filed DateMar 13, 2024
Risk Levellow
Pages4
Reading Time5 min
Sentimentneutral

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by Profound Medical Corp..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G/A filing submitted by Profound Medical Corp. (ticker: PROF) to the SEC on Mar 13, 2024.

What is the risk level of this SC 13G/A filing?

This filing has been assessed as low risk.

How long is this filing?

Profound Medical Corp.'s SC 13G/A filing is 4 pages with approximately 1,238 words. Estimated reading time is 5 minutes.

Where can I view the full SC 13G/A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 1,238 words · 5 min read · ~4 pages · Grade level 8.6 · Accepted 2024-03-13 16:00:16

Filing Documents

(a). Name of Issuer

Item 1(a). Name of Issuer: Profound Medical Corp.

(b). Address of Issuer’s Principal Executive Offices

Item 1(b). Address of Issuer’s Principal Executive Offices: 2400 Skymark Avenue Unit 6 Mississauga, Ontario L4W 5K5

(a). Name of Person Filing

Item 2(a). Name of Person Filing: This statement is filed by Don R. Daseke and Barbara S. Daseke. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on January 11, 2024, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

(b). Address of Principal Business Office or, if None, Residence

Item 2(b). Address of Principal Business Office or, if None, Residence: The address of the Reporting Persons is 7901 Windrose Ave., Unit 1504, Plano, Texas 75024.

(c). Citizenship

Item 2(c). Citizenship: Each of the Reporting Persons is a citizen of the United States of America.

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Shares, no par value (the “Shares”)

(e). CUSIP Number

Item 2(e). CUSIP Number: 74319B502 4 CUSIP No. 74319B502

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: /x/ Not applicable. (a) / / Broker or dealer registered under Section 15 of the Exchange Act. (b) / / Bank as defined in Section 3(a)(6) of the Exchange Act. (c) / / Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) / / Investment company registered under Section 8 of the Investment Company Act. (e) / / An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) / / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) / / A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) / / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) / / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) / / Non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J). (k) / / Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Ownership

Item 4. Ownership. (a) Amount beneficially owned: As of March 7, 2024, the Reporting Persons beneficially owned 1,105,000 Shares. (b) Percent of class: The aggregate percentage of Shares reported owned herein is based upon 24,428,899 Shares outstanding as of March 7, 2024, as reported in Exhibit 99.1 to the Issuer’s Current Report on Form 6-K filed with the Securities and Exchange Commission on March 7, 2024. As of March 7, 2024, the Reporting Persons beneficially owned approximately 4.5% of the outstanding Shares. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9. (ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9. 5 CUSIP No. 74319B502 (iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9. (iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the Report Persons have ceased to be the beneficial owners of more than 5 percent of the class of securities, check the following box [X].

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. See Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on January 11, 2024.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not Applicable.

Certifications

Item 10. Certifications. By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a–11. 6 CUSIP No. 74319B502 SIGNATURE After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: March 13, 2024 /s/ Don R. Daseke Don R. Daseke /s/ Barbara S. Daseke Barbara S. Daseke 7

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.